CHESTERFIELD, Mo., Jan. 16 /PRNewswire-FirstCall/ -- Reliv International, Inc. (Nasdaq: RELV), an international manufacturer and network marketer of nutritional supplements and other food technology products, today announced that its consolidated sales at retail for 2003 were in the range of $108 million to $110 million. Consolidated net sales for 2003 were in the range of $75 million to $77 million.
Robert L. Montgomery, Chief Executive Officer of the Company, said, "For the first time in our history, sales at retail for our Company in a year have exceeded $100 million and, in fact, approached the $110 million mark for 2003. This milestone has been reached because we have maintained a double-digit rate of growth over the past 18 months, both in the United States and in our international markets.
"This achievement results from the clear and focused vision of our management team and our distributor leadership. Together we are improving the lives of thousands, by providing the highest quality of nutrition, made simple, and financial opportunity for so many," he said.
Sales at retail for 2003 represent an increase of approximately 20% over sales at retail for 2002 and are the highest level of annual retail sales in the Company's history. Sales at retail represent the sales volume which would be achieved if all sales were made at suggested retail prices. Revenues represent the actual payments received by the Company from sales principally to its distributors.
Reliv International, Inc., based in suburban St. Louis, manufactures and distributes several lines of food products, including nutritional and fiber supplements, diet management products, functional foods and sports drink mixes. Its proprietary product lines include an extensive line of soy-based products. Reliv International's common stock trades on The Nasdaq Stock Market(R) under the symbol RELV.
NOTE: Any statement released by Reliv International, Inc. that is forward looking is made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Editors and investors are cautioned that forward-looking statements involve risk and uncertainties that may affect the Company's business prospect and performance. This includes economic, competitive, governmental, technological and other factors discussed in the Company's filings with the SEC on forms 10-K and 10-Q.